Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 EP269 | DOI: 10.1530/endoabs.81.EP269

Hedi Chaker University Hospital, Endocrinology, Tunisia


Introduction: Hypothyroidism has always been considered one of the most common endocrine etiologies of obesity. That said, would screening for hypothyroidism be justified in the face of obesity? The purpose of our study was to study the thyroid profile of obese people.

Patients and methods: We conducted a retrospective study which patients with obesity hospitalized in the diabetology endocrinology department, CHU Hédi Chaker of Sfax, between 01/10/2022 and 31/12/2022. for all patients who had consulted for obesity in which a thyroid assessment was requested as part of an etiological survey.

Results: the total number of patients was 70 obese, (12 men and 58 women), aged on average 44.57 years (±15 years). The average BMI of our patients was 38,38±6,09 k/m2. In our study population, 30% of patients were moderately obese; 34.3% were severely obese and 35.7% were morbidly obese. No subject was known to have a history of dysthyroidism. Among patients, 6.7% (n=5) had subclinical hypothyroidism with TSH higher than 4 μmol/l and a normal FT4. In the latter, a thyroid check-up was done after one month returning normal. The rest of the patients (n=65) had no abnormalities in their thyroid function. The analytical study did not find a correlation between TSH blood level and the BMI of patients (P=0.134).

Conclusion: Our study shows that hypothyroidism remains a secondary cause to look for in the face of obesity with signs of appeal in favor of diagnosis instead of a systematic screening that proves to be unjustified.

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.